Filter News
Area of Research
- (-) Isotopes (4)
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (2)
- Biology and Environment (25)
- Clean Energy (25)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (4)
- Fusion and Fission (1)
- Materials (10)
- Materials for Computing (2)
- Mathematics (1)
- National Security (17)
- Neutron Science (8)
- Quantum information Science (2)
- Supercomputing (20)
News Type
News Topics
- (-) Biomedical (6)
- (-) Transformational Challenge Reactor (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (7)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (2)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Fusion (3)
- Irradiation (1)
- Isotopes (19)
- Materials (2)
- Materials Science (2)
- Molten Salt (3)
- National Security (1)
- Neutron Science (3)
- Nuclear Energy (21)
- Physics (2)
- Security (1)
- Space Exploration (6)
- Sustainable Energy (1)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.